PARSIPPANY, NJ--(Marketwire - April 21, 2010) - The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, April 28, 2010 at 8:30 a.m. Eastern Time to discuss first quarter 2010 financial results and operational developments.
The conference call will be available via phone and webcast. The dial in information is listed below:
Domestic Dial In: 888-396-2384 International Dial In: 617-847-8711 Passcode for both dial in numbers: 37311704
Replay is available from 11:30 a.m. Eastern Time following the conference call through May 12, 2010. To hear a replay of the call dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 83209795.
This call is being webcast and can be accessed at The Medicines Company website at www.themedicinescompany.com.
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company’s website is www.themedicinescompany.com.
Contact:
Michael Mitchell
973-290-6000
investor.relations@themedco.com
